ABOUT THIS STUDY
- Any patient treated with pregabalin for an approved indication by Korean Food and Drug Administration
- Hypersensitivity to the active substance or to any of the excipients
- galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.